Page last updated: 2024-11-06

prednisolone and Granulomatosis, Orofacial

prednisolone has been researched along with Granulomatosis, Orofacial in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Granulomatosis, Orofacial: A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.

Research Excerpts

ExcerptRelevanceReference
"She was diagnosed with orofacial granulomatosis (OFG) and was treated conservatively for 7 years, with no evidence of systemic illness."1.42Orofacial granulomatosis as a presenting feature of Crohn's disease. ( Henson, S; Jennings, VC; Williams, L, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jennings, VC1
Williams, L1
Henson, S1

Other Studies

1 other study available for prednisolone and Granulomatosis, Orofacial

ArticleYear
Orofacial granulomatosis as a presenting feature of Crohn's disease.
    BMJ case reports, 2015, Jan-09, Volume: 2015

    Topics: Adolescent; Age of Onset; Crohn Disease; Feeding Behavior; Female; Granulomatosis, Orofacial; Humans

2015